TECX
Tectonic Therapeutic, Inc.
$20.07
-4.84%
2026-10-23
About Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.
Key Fundamentals
Forward P/E
-5.06
EPS (TTM)
$-4.57
ROE
-33.8%
Profit Margin
0.0%
Debt/Equity
1.97
Price/Book
1.93
Beta
0.22
Market Cap
$462.7M
Avg Volume (10D)
197K
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$38.85
60D Low
$19.83
Avg Volume
223K
Latest Close
$20.07
Get breakout alerts for TECX
Sign up for Breakout Scanner to receive daily notifications when TECX triggers breakout signals. Build custom AI screeners and backtest strategies.
Create your account7-day free trial, no card needed. Then $20/month.
Tectonic Therapeutic, Inc. (TECX) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors TECX daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. TECX operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.